Shenzhen Chipscreen Biosciences Co (688321) - Total Liabilities

Latest as of September 2025: CN¥1.98 Billion CNY ≈ $289.34 Million USD

Based on the latest financial reports, Shenzhen Chipscreen Biosciences Co (688321) has total liabilities worth CN¥1.98 Billion CNY (≈ $289.34 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Shenzhen Chipscreen Biosciences Co - Total Liabilities Trend (2016–2024)

This chart illustrates how Shenzhen Chipscreen Biosciences Co's total liabilities have evolved over time, based on quarterly financial data. See 688321 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Shenzhen Chipscreen Biosciences Co Competitors by Total Liabilities

The table below lists competitors of Shenzhen Chipscreen Biosciences Co ranked by their total liabilities.

Company	Country	Total Liabilities
Capricor Therapeutics Inc NASDAQ:CAPR	USA	$47.58 Million
Supreme Petrochem Limited NSE:SPLPETRO	India	Rs11.12 Billion
Byline Bancorp Inc NYSE:BY	USA	$8.63 Billion
Fila Holdings Corp KO:081660	Korea	₩2.75 Trillion
Kraken Robotics Inc V:PNG	Canada	CA$65.69 Million
SKYWORTH GRP UNSP.ADR/30 F:KYW0	Germany	€53.44 Billion
Devyani International Limited NSE:DEVYANI	India	Rs42.48 Billion
Arteche Lantegi Elkartea SA MC:ART	Spain	€347.10 Million

Liability Composition Analysis (2016–2024)

This chart breaks down Shenzhen Chipscreen Biosciences Co's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 688321 stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.87	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.19	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.54	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Shenzhen Chipscreen Biosciences Co's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Shenzhen Chipscreen Biosciences Co (2016–2024)

The table below shows the annual total liabilities of Shenzhen Chipscreen Biosciences Co from 2016 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥1.67 Billion ≈ $244.34 Million	+11.82%
2023-12-31	CN¥1.49 Billion ≈ $218.52 Million	+13.12%
2022-12-31	CN¥1.32 Billion ≈ $193.17 Million	+176.87%
2021-12-31	CN¥476.79 Million ≈ $69.77 Million	+105.12%
2020-12-31	CN¥232.44 Million ≈ $34.01 Million	-5.16%
2019-12-31	CN¥245.10 Million ≈ $35.87 Million	+2.36%
2018-12-31	CN¥239.44 Million ≈ $35.04 Million	+16.53%
2017-12-31	CN¥205.47 Million ≈ $30.07 Million	+8.30%
2016-12-31	CN¥189.73 Million ≈ $27.76 Million	--

About Shenzhen Chipscreen Biosciences Co

SHG:688321 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.51 Billion

CN¥10.29 Billion CNY

Market Cap Rank

#7297 Global

#1661 in China

Share Price

CN¥25.23

Change (1 day)

-0.90%

52-Week Range

CN¥23.75 - CN¥42.97

All Time High

CN¥102.00